UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Total revenue	$ 595,000,000.0	$ 554,700,000
Total cost of revenue	288,700,000	276,000,000.0
Gross profit	306,300,000	278,700,000
Operating expenses:
Selling, general and administrative	145,700,000	131,800,000
Research and development	56,600,000	54,800,000
Other charges, net	7,500,000	3,000,000.0
Total operating expenses	209,800,000	189,600,000
Operating income	96,500,000	89,100,000
Interest and other income (expense), net	(2,500,000)	(3,800,000)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	94,000,000.0	85,300,000
Income tax provision	31,900,000	27,500,000
Consolidated net income	62,100,000	57,800,000
Net income attributable to noncontrolling interests in consolidated subsidiaries	500,000	1,100,000
Net income attributable to Bruker Corporation	$ 61,600,000	$ 56,700,000
Net income per common share attributable to Bruker Corporation shareholders:
Basic	$ 0.41	$ 0.37
Diluted	$ 0.41	$ 0.37
Weighted average common shares outstanding:
Basic (in shares)	150.4	151.8
Diluted (in shares)	151.4	153.2
Comprehensive income	$ 53,200,000	$ 41,600,000
Less: Comprehensive income attributable to noncontrolling interests	200,000	900,000
Less: Comprehensive loss attributable to redeemable noncontrolling interest	(0.2)	0
Comprehensive income attributable to Bruker Corporation	53,200,000	40,700,000
Product
Total revenue	490,400,000	458,600,000
Total cost of revenue	229,000,000.0	220,900,000
Service
Total revenue	103,200,000	94,100,000
Total cost of revenue	59,600,000	54,800,000
Other
Total revenue	1,400,000	2,000,000.0
Total cost of revenue	$ 100,000	$ 300,000